The reported involvements of EFEMP1 in cancer, and its site of action in the extracellular compartment [9], suggested the possibility of developing an EFEMP1- derived tumor-suppressor protein (ETSP) that would suppress both growth and invasion phenotypes of cancer and the extracellular cancer-supporting microenvironments. Here, TCHP is linked to cancer.